Résultats de la recherche

Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements $65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in immuno-inflammation and immuno-oncology planned to enter...

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today...